Wolverine Trading’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15,450
Closed -$201K 6660
2021
Q3
$201K Buy
+15,450
New +$206K ﹤0.01% 5339
2018
Q3
Sell
-48,870
Closed -$320K 5697
2018
Q2
$320K Hold
48,870
﹤0.01% 3682
2018
Q1
$320K Buy
+48,870
New +$342K ﹤0.01% 3682
2017
Q3
Sell
-30,695
Closed -$252K 4901
2017
Q2
$252K Buy
+30,695
New +$250K ﹤0.01% 3291

Other funds holding RDY

Wolverine Trading's RDY Position: Q4 2021 in Review

Wolverine Trading sold out of Dr. Reddy's Laboratories (RDY) in Q4 2021, closing a stake of 15,450 shares — an estimated $201K sold.

Wolverine Trading first reported a position in RDY in Q2 2017 and held it in 4 quarters. The position peaked at $320K in Q2 2018. 147 funds tracked by Wall St. Rank hold RDY as of Q4 2021.

  • Wolverine Trading reported no remaining Dr. Reddy's Laboratories position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 15,450 Dr. Reddy's Laboratories shares in Q4 2021, an estimated $201K.
  • Wolverine Trading first reported a position in Dr. Reddy's Laboratories in Q2 2017 and held it in 4 quarters.
  • Wolverine Trading's Dr. Reddy's Laboratories position peaked at $320K in Q2 2018.
  • 147 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.